tiprankstipranks
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
US Market
Holding PRLD?
Track your performance easily

Prelude Therapeutics (PRLD) Technical Analysis

125 Followers

Technical Sentiment

Overall Consensus
Strong Sell
5Bullish
0Neutral
17Bearish
Technical Analysis Consensus
Neutral
5Bullish
0Neutral
5Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Prelude Therapeutics’s (PRLD) Moving Averages Convergence Divergence (MACD) indicator is -0.30, suggesting Prelude Therapeutics is a Sell.
Prelude Therapeutics’s (PRLD) 20-Day exponential moving average is 1.36, while Prelude Therapeutics’s (PRLD) share price is $1.04, making it a Sell.
Prelude Therapeutics’s (PRLD) 50-Day exponential moving average is 2.12, while Prelude Therapeutics’s (PRLD) share price is $1.04, making it a Sell.

Prelude Therapeutics (PRLD) Pivot Points

Nov 22, 2024, 11:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.90
0.96
0.99
1.05
1.08
1.14
1.17
Fibonacci
0.96
0.99
1.01
1.05
1.08
1.10
1.14
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Prelude Therapeutics (PRLD) Moving Averages

Nov 22, 2024, 11:23 AM
Period
Simple
Exponential
MA5
1.09Sell
1.09Sell
MA10
1.17Sell
1.17Sell
MA20
1.33Sell
1.36Sell
MA50
2.05Sell
2.12Sell
MA100
3.58Sell
2.90Sell
MA200
3.83Sell
3.32Sell
Prelude Therapeutics’s (PRLD) 10-Day exponential moving average is 1.17, while Prelude Therapeutics’s (PRLD) share price is $1.04, making it a Sell.
Prelude Therapeutics’s (PRLD) 100-Day exponential moving average is 2.90, while Prelude Therapeutics’s (PRLD) share price is $1.04, making it a Sell.
Prelude Therapeutics’s (PRLD) stock price is $1.04 and Prelude Therapeutics’s (PRLD) 50-day simple moving average is 2.05, creating a Sell signal.
Prelude Therapeutics’s (PRLD) stock price is $1.04 and Prelude Therapeutics’s (PRLD) 100-day simple moving average is 3.58, creating a Sell signal.
Prelude Therapeutics’s (PRLD) stock price is $1.04 and Prelude Therapeutics’s (PRLD) 200-day simple moving average is 3.83, creating a Sell signal.

Prelude Therapeutics (PRLD) Technical Indicators

Nov 22, 2024, 11:23 AM
Name
Value
Implied Action
RSI (14)
21.74
Buy
STOCH (9,6)
5.61
Buy
STOCHRSI (14)
3.69
Buy
MACD (12,26)
-0.30
Sell
ADX (14)
58.81
Sell
Williams %R
-92.45
Buy
CCI (14)
-110.53
Buy
ATR (14)
0.14
-
Ultimate Oscillator
26.60
Sell
ROC
-30.67
Sell
Prelude Therapeutics’s (PRLD) Relative Strength Index (RSI) is 21.74, creating a Buy signal.
Prelude Therapeutics’s (PRLD) Trend Strength Indicator (ADX) is 58.81, creating a Sell signal.
Prelude Therapeutics’s (PRLD) Commodity Channel Index (CCI) is -110.53, creating a Buy signal.
Prelude Therapeutics’s (PRLD) Price Rate of Change (ROC) is -30.67, creating a Sell signal.

FAQ

Is PRLD a Buy, Hold, or Sell?
Based on PRLD’s technical indicators, PRLD is a Strong Sell.
    What is PRLD’s RSI (14)?
    PRLD’s RSI (14) is 21.74, which suggests PRLD is a Buy.
      What is PRLD’s MACD?
      PRLD’s MACD is -0.30, which suggests PRLD is a Sell.
        What is PRLD’s 5-day moving average?
        PRLD’s 5-day moving average is 1.09, which suggests PRLD is a Sell.
          What is PRLD’s 20-day moving average?
          PRLD 20-day moving average is 1.33, which suggests PRLD is a Sell.
            What is PRLD’s 50-day moving average?
            PRLD’s 50-day moving average is 2.05, which suggests PRLD is a Sell.
              What is PRLD’s 200-day moving average?
              PRLD’s 200-day moving average is 3.83, which suggests PRLD is a Sell.
                What is PRLD’s Williams % R (14)?
                PRLD’s Williams % R (14) is -92.45, which suggests PRLD is a Buy.
                  What is PRLD’s CCI (14)?
                  PRLD’s CCI (14) is -110.53, which suggests PRLD is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis